Ram P. Kapil

992 total citations
46 papers, 731 citations indexed

About

Ram P. Kapil is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ram P. Kapil has authored 46 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 12 papers in Cellular and Molecular Neuroscience and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ram P. Kapil's work include Neuropeptides and Animal Physiology (12 papers), Opioid Use Disorder Treatment (9 papers) and Pain Management and Opioid Use (8 papers). Ram P. Kapil is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Opioid Use Disorder Treatment (9 papers) and Pain Management and Opioid Use (8 papers). Ram P. Kapil collaborates with scholars based in United States, India and Canada. Ram P. Kapil's co-authors include Stephen Harris, Shaker A. Mousa, Nikhilesh Singh, David J. Greenblatt, Thomas Roth, Jerold S. Harmatz, Alessandra Cipriano, Salvatore V. Colucci, Jeffrey M. Bozarth and Margaret Moline and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Blood.

In The Last Decade

Ram P. Kapil

45 papers receiving 698 citations

Peers

Ram P. Kapil
Willi Weber Germany
C. W. Hand United Kingdom
Christoph Wandel United States
C. Dubruc France
David W. J. Clark New Zealand
Michael Cwik United States
Jean T. Barbey United States
Willi Weber Germany
Ram P. Kapil
Citations per year, relative to Ram P. Kapil Ram P. Kapil (= 1×) peers Willi Weber

Countries citing papers authored by Ram P. Kapil

Since Specialization
Citations

This map shows the geographic impact of Ram P. Kapil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram P. Kapil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram P. Kapil more than expected).

Fields of papers citing papers by Ram P. Kapil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ram P. Kapil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram P. Kapil. The network helps show where Ram P. Kapil may publish in the future.

Co-authorship network of co-authors of Ram P. Kapil

This figure shows the co-authorship network connecting the top 25 collaborators of Ram P. Kapil. A scholar is included among the top collaborators of Ram P. Kapil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram P. Kapil. Ram P. Kapil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Stephen, Alessandra Cipriano, Salvatore V. Colucci, et al.. (2015). Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users. Pain Medicine. 17(5). 820–831. 21 indexed citations
3.
Kapil, Ram P., Alessandra Cipriano, Warren Wen, et al.. (2015). Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties. Clinical Therapeutics. 38(2). 302–314. 4 indexed citations
4.
Greenblatt, David J., Jerold S. Harmatz, Nikhilesh Singh, et al.. (2014). Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects. Drugs & Aging. 31(10). 731–736. 10 indexed citations
5.
Kapil, Ram P., Alessandra Cipriano, Manjunath S. Shet, et al.. (2012). Once-Weekly Transdermal Buprenorphine Application Results in Sustained and Consistent Steady-State Plasma Levels. Journal of Pain and Symptom Management. 46(1). 65–75. 30 indexed citations
6.
Roy, Partha Pratim, et al.. (2005). Effect of Multiple‐Dose Dexloxiglumide on the Pharmacokinetics of Oral Contraceptives in Healthy Women. The Journal of Clinical Pharmacology. 45(3). 329–336. 8 indexed citations
7.
Jakate, Abhijeet, et al.. (2005). Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. British Journal of Clinical Pharmacology. 60(5). 498–507. 5 indexed citations
8.
Kapil, Ram P., Arno Nolting, Partha Pratim Roy, et al.. (2004). Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: Two randomized, open-label, crossover studies in healthy adult volunteers. Clinical Therapeutics. 26(12). 2015–2025. 19 indexed citations
9.
Webber, Colin E., Clare Stokes, Stefano Persiani, et al.. (2004). Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog. European Journal of Drug Metabolism and Pharmacokinetics. 29(1). 15–23. 1 indexed citations
10.
Joshi, Hemant, et al.. (2003). Characterization of Dexloxiglumide in vitro Biopharmaceutical Properties and Active Transport. Journal of Pharmaceutical Sciences. 92(10). 1968–1980. 10 indexed citations
11.
Webber, Colin E., Angelika Roth, Stefano Persiani, et al.. (2003). Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects. Xenobiotica. 33(6). 625–641. 13 indexed citations
12.
Webber, Colin E., Clare Stokes, Stefano Persiani, et al.. (2003). Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat. European Journal of Drug Metabolism and Pharmacokinetics. 28(3). 201–212. 2 indexed citations
13.
Barrett, Jeffrey S., Jun Yu, Ram P. Kapil, et al.. (1999). Disposition and exposure of the fibrinogen receptor antagonist XV459 on αIIBβ3 binding sites in the guinea pig. Biopharmaceutics & Drug Disposition. 20(6). 309–318. 6 indexed citations
14.
Mousa, Shaker A., Richard E. Olson, Jeffrey M. Bozarth, et al.. (1998). Oral Antiplatelet Efficacy and Specificity of a Novel Nonpeptide Platelet GPIIb/IIIa Receptor Antagonist, DMP 802. Journal of Cardiovascular Pharmacology. 32(2). 169–176. 13 indexed citations
15.
Mousa, Shaker A., Mark S. Forsythe, William Lorelli, et al.. (1996). Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754. Coronary Artery Disease. 7(10). 767–774. 41 indexed citations
16.
Wu, Steven T., Herman F. Stampfli, Thomas Emm, et al.. (1994). Determination of DMP 728, a receptor antagonist, in rat and dog plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 657(1). 254–260. 2 indexed citations
17.
Kapil, Ram P., et al.. (1992). Nanogram level quantitation of oxycodone in human plasma by capillary gas chromatography using nitrogen—phosphorus selective detection. Journal of Chromatography B Biomedical Sciences and Applications. 577(2). 283–287. 9 indexed citations
18.
Bruyere, Harold J. & Ram P. Kapil. (1990). Cardioteratogenic dose of ethanol in the chick embryo results in egg white concentrations comparable to human blood alcohol levels. Journal of Applied Toxicology. 10(1). 69–71. 8 indexed citations
19.
Kapil, Ram P. & Harold J. Bruyere. (1989). Applicability of capillary gas chromatography to study caffeine distribution in the developing chicken egg. Journal of Chromatography B Biomedical Sciences and Applications. 493(1). 182–187. 1 indexed citations
20.
Kapil, Ram P., et al.. (1988). New Cycloartenol Derivatives fromAglaia roxburghiana1. Planta Medica. 54(1). 40–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026